Literature DB >> 6556977

Characteristics of a benign subtype of dense deposit disease: comparison with the progressive form of this disease.

M Klein, S Poucell, G S Arbus, M McGraw, C P Rance, S J Yoon, R Baumal.   

Abstract

Pathologic, clinical and serum complement studies were performed on 18 patients with dense deposit disease (DDD). The patients were divided into 3 groups: group A (10 patients who developed end-stage renal failure within 2.9 +/- 1.0 years of onset) group B (3 patients who developed elevated serum creatinines within 6.8 +/- 4.8 years of onset) and group C (5 patients with no evidence of renal insufficiency after 11.0 +/- 1.4 years of follow-up). Renal biopsies from all patients showed intramembranous, electron-dense deposits in glomerular capillary basement membranes. Most group A and B patients presented with a nephritic and/or nephrotic syndrome and followed an active clinical course. In contrast, group C patients presented with either a nephrotic syndrome or asymptomatic proteinuria +/- hematuria and followed a benign course. Sera from group A and B patients contained reduced concentrations of C3 and factor B and large amounts of C3 nephritic factor (NeF) activity. In contrast, serum of group C patients contained normal amounts of C3 and factor B and low levels of C3 NeF activity. These studies show that some patients with DDD (group C) have a benign illness and that they can be identified by serum levels of C3, factor B and C3 NeF activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6556977

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

1.  A case of regression of atypical dense deposit disease without C3 deposition in a child.

Authors:  Min Sun Kim; Pyoung Han Hwang; Mung Jae Kang; Dae-Yeol Lee
Journal:  Korean J Pediatr       Date:  2010-07-31

2.  Causes of alternative pathway dysregulation in dense deposit disease.

Authors:  Yuzhou Zhang; Nicole C Meyer; Kai Wang; Carla Nishimura; Kathy Frees; Michael Jones; Louis M Katz; Sanjeev Sethi; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

3.  Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.

Authors:  Samih H Nasr; Anthony M Valeri; Gerald B Appel; Julius Sherwinter; Michael B Stokes; Samar M Said; Glen S Markowitz; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-29       Impact factor: 8.237

4.  Dense deposit disease and the factor H H402 allele.

Authors:  Keith K Lau; Richard J Smith; Peter C Kolbeck; Lavjay Butani
Journal:  Clin Exp Nephrol       Date:  2008-01-26       Impact factor: 2.801

5.  Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases.

Authors:  Marloes A H M Michels; Nicole C A J van de Kar; Marcin Okrój; Anna M Blom; Sanne A W van Kraaij; Elena B Volokhina; Lambertus P W J van den Heuvel
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

Review 6.  Dense deposit disease and C3 glomerulopathy.

Authors:  Thomas D Barbour; Matthew C Pickering; H Terence Cook
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.